Chengdu Climb Pharmaceutical Technology Co.,Ltd.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
6/10
Chengdu Climb Pharmaceutical Technology Co.,Ltd.
We have been a professional supplier of API ,Intermediates since 2013.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
6/10
Apixaban is an oral, direct, and highly selective factor Xa (FXa) inhibitor (of both free and prothrombinase-bound FXa independently of antithrombin III) for the prevention and treatment of thromboembolic diseases. It is marketed under the name Eliquis. FDA approved on December 28, 2012.